Russell Clark Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,534	Closed	-$1.29M	–	50
2018 Q3	$1.29M	Buy	+7,534	New	+$1.29M	0.3%	55